Correction to: Aldehyde dehydrogenase 3A1 deficiency leads to mitochondrial dysfunction and impacts salivary gland stem cell phenotype
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer, Hypoxia, and Metabolism
This is a correction to: Vignesh Viswanathan, Hongbin Cao, Julie Saiki, Dadi Jiang, Aaron Mattingly, Dhanya Nambiar, Joshua Bloomstein, Yang Li, Sizun Jiang, Manish Chamoli, Davud Sirjani, Michael Kaplan, F Christopher Holsinger, Rachel Liang, Rie Von Eyben, Haowen Jiang, Li Guan, Edward Lagory, Zhiping Feng, Garry Nolan, Jiangbin Ye, Nicholas Denko, Sarah Knox, Daria-Mochly Rosen, Quynh-Thu Le, Aldehyde dehydrogenase 3A1 deficiency leads to mitochondrial dysfunction and impacts salivary gland stem cell phenotype, PNAS Nexus, Volume 1, Issue 2, May 2022, pgac056, https://doi.org/10.1093/pnasnexus/pgac056
During a retroactive audit conducted by PNAS Nexus, it was discovered that this paper was missing a statement acknowledging compliance with the PNAS Nexus Human and Animal Participants and Clinical Trials policy:
Our full study protocol involving human participants was approved by the Stanford IRB panel 3 under the protocol number 11977.
This error has been corrected in the original article.